FDX vs JAZZ · P/E 18, rev $94.72B vs P/E 1988, rev $2.28B
FedEx Corporation (FDX) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
FedEx Corporation (FDX) is a integrated freight & logistics company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported FDX revenue for 2026-05-31 was $94.72B. Net income was $4.43B. Revenue was up 7.7% from 2025-05-31 to 2026-05-31. FDX currently screens at market cap $78.98B and trailing P/E 17.7.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
FDX currently screens at market cap $78.98B and trailing P/E 17.7. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the FDX and JAZZ stock pages for the full models.
Not investment advice.